Stay updated with breaking news from Research Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Van ECK Associates Corp trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during […]
Van ECK Associates Corp lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during the period. Van ECK Associates […]
Investment House LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,126 shares of the medical research company’s stock after selling 706 shares during the quarter. Charles […]
Valmark Advisers Inc. bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,000 shares of the medical research company’s stock, valued at approximately $709,000. Other hedge funds […]
New York State Common Retirement Fund reduced its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 131,078 shares of the medical research company’s stock after selling 5,565 shares during the […]